San Francisco, California-- (Newsfile Corp. - January 30, 2025) - BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from ...

It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after ...

BioAge Labs has given up on its lead obesity candidate. Weeks after stopping a trial in response to phase 2 data, the biotech has jettisoned the molecule and shifted its focus to a preclinical ...

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic ...

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...

This article explores the primary differences between manganese and magnesium, as well as each nutrient's uses, deficiencies, and special considerations.

For many women who experience hot flashes, the new drug Veozah has been a life-changer. And a heightened warning last month, doesn’t seem to be dampening that enthusiasm.

The team evaluated more than 4,000 clones before identifying an enzyme S N Ar1.3 that contains six mutations and is 160-fold more active than the parent enzyme.

Mango heard my plea for the perfect elevated pant and dropped this snakeskin effect faux-leather style. They feature a straight-leg fit, come in all-black or a beige mix, and have a high-shine ...

and administration may result in elevations of liver enzymes (such as GGT, GLDH, ALT, AST) or total bilirubin, typically seen within 8 weeks. Patients with preexisting liver impairment ...

The elevated risk persisted ... The findings align with current guidelines recommending liver enzyme monitoring in the medical follow-up of patients with celiac disease. "In addition to being ...